Merck successfully completes the second REACH registration phase
At the end of May 2013, Merck registered a further 70 substances in accordance with the European REACH Regulation. At the end of the first registration phase on November 30, 2010, Merck had already registered around 100 substances under the REACH Regulation with the European Chemicals Agency (ECHA) in Helsinki, and thus proven the safe use of these substances.
"In parallel to the now well-established registration procedures, we have begun to prepare the application for authorization of SVHC substances," says Michael Siebold, head of the Corporate Regulatory Affairs unit and responsible for product safety in the Merck Group. SVHC stands for Substance of Very High Concern. "As these substances are under great pressure for substitution and are ultimately to disappear from the EU market, for all companies in the supply chain this involves a high economic risk and expense for successfully completing an authorization procedure."
Other news from the department business & finance
